array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Oppenheimer Holdings Inc."
["slug"]=>
string(33) "d9d67-us-oppenheimer-holdings-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/a99751a9-e5ba-47be-b7b8-15581b246381"
["description"]=>
string(1060) "Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions.
We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking.
Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer. "
["address_street"]=>
string(17) "85 Broad St FL 22"
["address_place"]=>
string(8) "New York"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1881-02-13"
["website_domain"]=>
string(8) "opco.com"
["website_url"]=>
string(20) "https://www.opco.com"
["industry_codes"]=>
array(3) {
[0]=>
string(50) "Security Brokers, Dealers, and Flotation Companies"
[1]=>
string(33) "Offices of Bank Holding Companies"
[2]=>
string(39) "Management Investment Offices, Open-End"
}
["employee_count"]=>
int(7)
["article_count"]=>
int(321)
}
["articles"]=>
array(2) {
[0]=>
array(7) {
["title_en"]=>
string(108) "Van ECK Associates Corp Purchases 15,893 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)"
["snippet_en"]=>
string(300) "Van ECK Associates Corp raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Get Rating) by 35.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,199 shares of the medical research company"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-crl-sec-filing-2023-05-08/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/33e5357c-231f-49cb-b1b1-1142edf31f4b"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-05-08"
["categories"]=>
array(4) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(18) "General Investment"
[2]=>
string(15) "Market Movement"
[3]=>
string(24) "Stock Research & Ratings"
}
}
[1]=>
array(7) {
["title_en"]=>
string(90) "Gulf International Bank UK Ltd Purchases 22,000 Shares of Boston Scientific Co. (NYSE:BSX)"
["snippet_en"]=>
string(296) "Gulf International Bank UK Ltd boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Get Rating) by 7.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 303,176 shares of the medical equipment provider'"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-bsx-sec-filing-2023-05-05/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b06dc367-6234-4486-816a-9187b3950c28"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-05-05"
["categories"]=>
array(5) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(12) "Stock Market"
[2]=>
string(24) "Stock Research & Ratings"
[3]=>
string(18) "General Investment"
[4]=>
string(15) "Market Movement"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(55)
}
[1]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(37)
}
[2]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(27)
}
[3]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(16)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(12)
}
[6]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[7]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(7)
}
[8]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(5)
}
[9]=>
array(2) {
["name"]=>
string(15) "Corporate Fines"
["count"]=>
int(4)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(3)
}
[11]=>
array(2) {
["name"]=>
string(5) "Fraud"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(17) "Commodity Pricing"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(1)
}
[22]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(1)
}
[23]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(12) "Slash Prices"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(5) "SPACs"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(10) "Tax Havens"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(8) "Accident"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(9) "Valuation"
["count"]=>
int(1)
}
}
}
d9d67-us-oppenheimer-holdings-inc
Oppenheimer Holdings Inc.
Location
New York
Founded
1881-02-13
Website
https://www.opco.com
Articles
321 Articles
Category
Security Brokers, Dealers, and Flotation Companies
Offices of Bank Holding Companies
Management Investment Offices, Open-End
Description
Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions.
We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking.
Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer.
Van ECK Associates Corp raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Get Rating) by 35.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,199 shares of the medical research company
Gulf International Bank UK Ltd boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Get Rating) by 7.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 303,176 shares of the medical equipment provider'
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.